Pharma industry experts indicate that strategy in 2026 is shifting to agentic AI, sustainable efficiency, and resilient supply chains to manage tariffs, regulations, and digitalization.
There are hundreds of cell types in the human body, each with a specific role spelled out in their DNA. In theory, all it ...